本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Corbus Pharmaceuticals Holdings, Inc.

7.39
+0.700010.46%
盘后7.670.2800+3.79%19:25 EDT
成交量:21.00万
成交额:150.62万
市值:9,039.62万
市盈率:-2.01
高:7.47
开:6.87
低:6.83
收:6.69
数据加载中...
2024/03/18

SEC问询函

Form CORRESP - Correspondence
2024/03/18

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

重要事件披露

Form 8-K - Current report
2024/02/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

重要事件披露

Form 8-K - Current report
2024/02/02

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/01

重要事件披露

Form 8-K - Current report
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/29

重要事件披露

Form 8-K - Current report
2024/01/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals